[Selinexor 对急性髓性白血病 Kasumi-1 细胞增殖和凋亡的影响]

Lu-Hui Lin, Sun-Qiao Gao, Xu-Qiao Mei, Da-Yi Lin, Yi-Feng Chen, Su-Dan Lin, Li-Hong Zhuang, Cong-Meng Lin
{"title":"[Selinexor 对急性髓性白血病 Kasumi-1 细胞增殖和凋亡的影响]","authors":"Lu-Hui Lin, Sun-Qiao Gao, Xu-Qiao Mei, Da-Yi Lin, Yi-Feng Chen, Su-Dan Lin, Li-Hong Zhuang, Cong-Meng Lin","doi":"10.19746/j.cnki.issn.1009-2137.2024.04.017","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To investigate the effects of selinexor, a inhibitor of nuclear export protein 1 (XPO1) on the proliferation inhibition and apoptosis of Kasumi-1 cells in acute myeloid leukemia (AML).</p><p><strong>Methods: </strong>MTS method was used to detect the inhibitory effect of different concentrations of selinexor on the proliferation of Kasumi-1 cells at different time points. The apoptosis rate and cell cycle changes after treatment with different concentration of selinexor were detected by flow cytometry.</p><p><strong>Results: </strong>Selinexor inhibited the growth of Kasumi-1 cells at different time points in a concentration-dependent manner (<i>r</i> <sub>24 h</sub>=0.7592, <i>r</i> <sub>48 h</sub>=0.9456, and <i>r</i> <sub>72 h</sub>=0.9425). Selinexor inhibited Kasumi-1 cells growth in a time-dependent manner (<i>r</i> =0.9057 in 2.5 μmol/L group, <i>r</i> =0.9897 in 5 μmol/L group and <i>r</i> =0.9994 in 10 μmol/L group). Selinexor could induce apoptosis of Kasumi-1 cells in a dose-dependent manner (<i>r</i> =0.9732), and the apoptosis of Kasumi-1 cells was more obvious with the increase of drug concentration. The proportion of G<sub>0</sub>/G<sub>1</sub> phase was significantly increased and the proportion of S phase was significantly decreased after the treatment of Kasumi-1 cells by selinexor. With the increase of drug concentration, the proportion of Kasumi-1 cells cycle arrest in G<sub>0</sub>/G<sub>1</sub> phase was increased and the cell synthesis was decreased.</p><p><strong>Conclusion: </strong>Selinexor can promote the death of tumor cells by inhibiting Kasumi-1 cells proliferation, inducing apoptosis and blocking cell cycle.</p>","PeriodicalId":35777,"journal":{"name":"中国实验血液学杂志","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Effect of Selinexor on Proliferation and Apoptosis of Acute Myeloid Leukemia Kasumi-1 Cells].\",\"authors\":\"Lu-Hui Lin, Sun-Qiao Gao, Xu-Qiao Mei, Da-Yi Lin, Yi-Feng Chen, Su-Dan Lin, Li-Hong Zhuang, Cong-Meng Lin\",\"doi\":\"10.19746/j.cnki.issn.1009-2137.2024.04.017\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>To investigate the effects of selinexor, a inhibitor of nuclear export protein 1 (XPO1) on the proliferation inhibition and apoptosis of Kasumi-1 cells in acute myeloid leukemia (AML).</p><p><strong>Methods: </strong>MTS method was used to detect the inhibitory effect of different concentrations of selinexor on the proliferation of Kasumi-1 cells at different time points. The apoptosis rate and cell cycle changes after treatment with different concentration of selinexor were detected by flow cytometry.</p><p><strong>Results: </strong>Selinexor inhibited the growth of Kasumi-1 cells at different time points in a concentration-dependent manner (<i>r</i> <sub>24 h</sub>=0.7592, <i>r</i> <sub>48 h</sub>=0.9456, and <i>r</i> <sub>72 h</sub>=0.9425). Selinexor inhibited Kasumi-1 cells growth in a time-dependent manner (<i>r</i> =0.9057 in 2.5 μmol/L group, <i>r</i> =0.9897 in 5 μmol/L group and <i>r</i> =0.9994 in 10 μmol/L group). Selinexor could induce apoptosis of Kasumi-1 cells in a dose-dependent manner (<i>r</i> =0.9732), and the apoptosis of Kasumi-1 cells was more obvious with the increase of drug concentration. The proportion of G<sub>0</sub>/G<sub>1</sub> phase was significantly increased and the proportion of S phase was significantly decreased after the treatment of Kasumi-1 cells by selinexor. With the increase of drug concentration, the proportion of Kasumi-1 cells cycle arrest in G<sub>0</sub>/G<sub>1</sub> phase was increased and the cell synthesis was decreased.</p><p><strong>Conclusion: </strong>Selinexor can promote the death of tumor cells by inhibiting Kasumi-1 cells proliferation, inducing apoptosis and blocking cell cycle.</p>\",\"PeriodicalId\":35777,\"journal\":{\"name\":\"中国实验血液学杂志\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"中国实验血液学杂志\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.19746/j.cnki.issn.1009-2137.2024.04.017\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"中国实验血液学杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.19746/j.cnki.issn.1009-2137.2024.04.017","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

研究目的研究核输出蛋白1(XPO1)抑制剂selinexor对急性髓性白血病(AML)Kasumi-1细胞增殖抑制和凋亡的影响:方法:采用 MTS 法检测不同浓度的 selinexor 在不同时间点对 Kasumi-1 细胞增殖的抑制作用。方法:采用MTS法检测不同浓度Selinexor对不同时间点Kasumi-1细胞增殖的抑制作用,流式细胞术检测不同浓度Selinexor处理后细胞的凋亡率和细胞周期变化:结果:Selinexor对不同时间点Kasumi-1细胞的生长抑制作用呈浓度依赖性(r 24 h=0.7592,r 48 h=0.9456,r 72 h=0.9425)。Selinexor抑制Kasumi-1细胞生长的作用与时间有关(2.5 μmol/L组r=0.9057,5 μmol/L组r=0.9897,10 μmol/L组r=0.9994)。Selinexor 能诱导 Kasumi-1 细胞凋亡,且呈剂量依赖性(r =0.9732),随着药物浓度的增加,Kasumi-1 细胞的凋亡更为明显。西利奈索处理Kasumi-1细胞后,G0/G1期比例明显增加,S期比例明显下降。随着药物浓度的增加,Kasumi-1细胞周期停滞在G0/G1期的比例增加,细胞合成减少:结论:Selinexor能通过抑制Kasumi-1细胞增殖、诱导细胞凋亡和阻滞细胞周期来促进肿瘤细胞的死亡。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[Effect of Selinexor on Proliferation and Apoptosis of Acute Myeloid Leukemia Kasumi-1 Cells].

Objective: To investigate the effects of selinexor, a inhibitor of nuclear export protein 1 (XPO1) on the proliferation inhibition and apoptosis of Kasumi-1 cells in acute myeloid leukemia (AML).

Methods: MTS method was used to detect the inhibitory effect of different concentrations of selinexor on the proliferation of Kasumi-1 cells at different time points. The apoptosis rate and cell cycle changes after treatment with different concentration of selinexor were detected by flow cytometry.

Results: Selinexor inhibited the growth of Kasumi-1 cells at different time points in a concentration-dependent manner (r 24 h=0.7592, r 48 h=0.9456, and r 72 h=0.9425). Selinexor inhibited Kasumi-1 cells growth in a time-dependent manner (r =0.9057 in 2.5 μmol/L group, r =0.9897 in 5 μmol/L group and r =0.9994 in 10 μmol/L group). Selinexor could induce apoptosis of Kasumi-1 cells in a dose-dependent manner (r =0.9732), and the apoptosis of Kasumi-1 cells was more obvious with the increase of drug concentration. The proportion of G0/G1 phase was significantly increased and the proportion of S phase was significantly decreased after the treatment of Kasumi-1 cells by selinexor. With the increase of drug concentration, the proportion of Kasumi-1 cells cycle arrest in G0/G1 phase was increased and the cell synthesis was decreased.

Conclusion: Selinexor can promote the death of tumor cells by inhibiting Kasumi-1 cells proliferation, inducing apoptosis and blocking cell cycle.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
中国实验血液学杂志
中国实验血液学杂志 Medicine-Medicine (all)
CiteScore
0.40
自引率
0.00%
发文量
7331
期刊介绍:
期刊最新文献
[Clinical Analysis of Epstein-Barr Virus Infection after Allogeneic Hematopoietic Stem Cell Transplantation]. [Clinical Analysis of PD-1 Inhibitor Combined with Lenalidomide in Treatment of Relapsed CD5+ Diffuse Large B-Cell Lymphoma]. [Clinical Characteristics Analysis of EBV-associated Hemophagocytic Lymphohistiocytosis Patients with Acute Kidney Injury]. [Clinical Characteristics and Prognosis of Myelodysplastic Syndromes Patients with RUNX1 Gene Mutation]. [Clinical Characteristics and Prognosis of Patients with Primary Bone Marrow Lymphoma].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1